Table 1.
Clinical presentation of patients.
| First study (clinical performance) |
Second study (routine care) |
|||
|---|---|---|---|---|
| RT-PCR+ | Pre-pandemic control group | RT-PCR- | RT-PCR+ | |
| Nb | 63 | 89 | 181 | 22 |
| Age (median/IQR) | 79/67−90 | 30/11−54 | 39/30−50 | 49/31−58 |
| Sex (F:M) | 1.52 | 1.17 | 1.51 | 1.75 |
| Severe outcome | 19/63 (30.2 %) | N/A | N/A | 0 |
| ICU | 18/63 (28.6 %) | NA | N/A | 0 |
| Death | 3/63 (4.7 %) | NA | N/A | 0 |
SARS-CoV-2 RT-PCR assays: Allplex™ 2019-nCOV (Seegene), Abbott RealTime SARS-CoV-2 or Bosphore 2019-nCoV (Anatolia GeneWorks); NA: not available; ICU: intensive care unit.